EP3635119A4 - Zusammensetzungen und verfahren zur genomeditierung - Google Patents

Zusammensetzungen und verfahren zur genomeditierung Download PDF

Info

Publication number
EP3635119A4
EP3635119A4 EP18813973.7A EP18813973A EP3635119A4 EP 3635119 A4 EP3635119 A4 EP 3635119A4 EP 18813973 A EP18813973 A EP 18813973A EP 3635119 A4 EP3635119 A4 EP 3635119A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
genome editing
editing
genome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18813973.7A
Other languages
English (en)
French (fr)
Other versions
EP3635119A2 (de
Inventor
John Lindbo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vilmorin SA
Original Assignee
Vilmorin SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vilmorin SA filed Critical Vilmorin SA
Publication of EP3635119A2 publication Critical patent/EP3635119A2/de
Publication of EP3635119A4 publication Critical patent/EP3635119A4/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8213Targeted insertion of genes into the plant genome by homologous recombination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/20Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
EP18813973.7A 2017-06-09 2018-06-07 Zusammensetzungen und verfahren zur genomeditierung Pending EP3635119A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762517360P 2017-06-09 2017-06-09
PCT/US2018/036480 WO2018226972A2 (en) 2017-06-09 2018-06-07 Compositions and methods for genome editing

Publications (2)

Publication Number Publication Date
EP3635119A2 EP3635119A2 (de) 2020-04-15
EP3635119A4 true EP3635119A4 (de) 2021-04-14

Family

ID=64566013

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18813973.7A Pending EP3635119A4 (de) 2017-06-09 2018-06-07 Zusammensetzungen und verfahren zur genomeditierung

Country Status (5)

Country Link
US (1) US11845942B2 (de)
EP (1) EP3635119A4 (de)
IL (1) IL271232A (de)
MA (1) MA52134A (de)
WO (1) WO2018226972A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA52134A (fr) 2017-06-09 2020-04-15 Vilmorin & Cie Compositions et procédés pour l'édition génomique
US20210238612A1 (en) 2018-07-12 2021-08-05 Keygene N.V. Type v crispr/nuclease-system for genome editing in plant cells
JP2022533589A (ja) * 2019-05-13 2022-07-25 イーエムディ・ミリポア・コーポレイション Crisprタンパク質をコードする合成自己複製rnaベクターおよびその使用
EP3973062A1 (de) * 2019-05-23 2022-03-30 Nomad Bioscience GmbH Rna-virales rna-molekül zum gen-editing
EP3987039A1 (de) * 2019-06-19 2022-04-27 Betterseeds Ltd. Verfahren zur erhöhung der cannabisausbeute durch geneditierung
EP4063500A4 (de) * 2019-11-18 2023-12-27 Suzhou Qi Biodesign biotechnology Company Limited Aus flavobakterien stammendes geneditierungssystem
US20230357796A1 (en) * 2019-11-27 2023-11-09 Danmarks Tekniske Universitet Constructs, compositions and methods thereof having improved genome editing efficiency and specificity
CN115552001A (zh) * 2020-05-15 2022-12-30 孟山都技术公司 用于检测基因组编辑的系统和方法
CN112626275A (zh) * 2021-01-14 2021-04-09 北京市农林科学院 基于一步法rt-pcr技术检测或辅助检测南方番茄病毒的引物对和方法
CN113355337B (zh) * 2021-04-14 2023-06-20 河南农业大学 一种创制地黄杂合突变体的方法及应用
JP2024513588A (ja) 2021-04-15 2024-03-26 キージーン ナムローゼ フェンノートシャップ 遺伝性突然変異のための可動性エンドヌクレアーゼ
IL305936A (en) 2021-04-15 2023-11-01 Keygene Nv Integrated regeneration of recalcitrant plants
MX2024005239A (es) * 2021-11-01 2024-07-22 Flagship Pioneering Innovations Vii Llc Polinucleotidos para modificar organismos.
WO2023111225A1 (en) 2021-12-17 2023-06-22 Keygene N.V. Double decapitation of plants
WO2024133851A1 (en) 2022-12-22 2024-06-27 Keygene N.V. Regeneration by protoplast callus grafting

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316931A (en) 1988-02-26 1994-05-31 Biosource Genetics Corp. Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes
US5959185A (en) 1998-02-13 1999-09-28 Pioneer Hi-Bred International, Inc. Soybean variety 95B41
US5973234A (en) 1998-02-13 1999-10-26 Pioneer Hi-Bred International, Inc. Soybean variety 95B33
US5977445A (en) 1998-06-30 1999-11-02 Pioneer Hi-Bred International, Inc. Soybean variety 91B64
IL150439A0 (en) * 2000-01-04 2002-12-01 Ruiter Seeds C V Lp De Cultivated tomato plant having increased brix value and method of producing same
US8936937B2 (en) 2007-01-29 2015-01-20 The Ohio State University Research Foundation System for expression of genes in plants from a virus-based expression vector
FR2925918A1 (fr) 2007-12-28 2009-07-03 Pasteur Institut Typage et sous-typage moleculaire de salmonella par identification des sequences nucleotidiques variables des loci crispr
US9102936B2 (en) 2012-06-11 2015-08-11 Agilent Technologies, Inc. Method of adaptor-dimer subtraction using a CRISPR CAS6 protein
US20140310830A1 (en) 2012-12-12 2014-10-16 Feng Zhang CRISPR-Cas Nickase Systems, Methods And Compositions For Sequence Manipulation in Eukaryotes
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
EP3825401A1 (de) 2012-12-12 2021-05-26 The Broad Institute, Inc. Systeme, verfahren und zusammensetzungen mit crispr-cas-komponenten zur sequenzmanipulation
AU2014227831B2 (en) 2013-03-15 2020-01-30 Regents Of The University Of Minnesota Engineering plant genomes using CRISPR/Cas systems
WO2015189693A1 (en) 2014-06-12 2015-12-17 King Abdullah University Of Science And Technology Targeted viral-mediated plant genome editing using crispr/cas9
EP3230452A1 (de) * 2014-12-12 2017-10-18 The Broad Institute Inc. Totführungen für crispr-transkriptionsfaktoren
MA52134A (fr) 2017-06-09 2020-04-15 Vilmorin & Cie Compositions et procédés pour l'édition génomique

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LE CONG ET AL: "Multiplex Genome Engineering Using CRISPR/Cas Systems", SCIENCE, vol. 339, no. 6121, 14 February 2013 (2013-02-14), US, pages 819 - 823, XP055458249, ISSN: 0036-8075, DOI: 10.1126/science.1231143 *
PRASHANT MALI ET AL: "CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering", NATURE BIOTECHNOLOGY, vol. 31, no. 9, 1 September 2013 (2013-09-01), us, pages 833 - 838, XP055693154, ISSN: 1087-0156, DOI: 10.1038/nbt.2675 *
SEUNG WOO CHO ET AL: "Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease (includes Supplementary information)", NATURE BIOTECHNOLOGY, GALE GROUP INC., NEW YORK, US, vol. 31, no. 3, 1 March 2013 (2013-03-01), pages 230 - 232, 1, XP002699850, ISSN: 1087-0156, [retrieved on 20130129], DOI: 10.1038/NBT.2507 *

Also Published As

Publication number Publication date
EP3635119A2 (de) 2020-04-15
WO2018226972A2 (en) 2018-12-13
US20200199605A1 (en) 2020-06-25
MA52134A (fr) 2020-04-15
IL271232A (en) 2020-01-30
US11845942B2 (en) 2023-12-19
WO2018226972A3 (en) 2020-02-20

Similar Documents

Publication Publication Date Title
EP3691747A4 (de) Zusammensetzungen und verfahren zum editing von rna
EP3353309A4 (de) Zusammensetzungen und verfahren zur genomeditierung
EP3635119A4 (de) Zusammensetzungen und verfahren zur genomeditierung
EP3864152A4 (de) Verfahren und zusammensetzungen zum editieren von rnas
GB2587970B (en) Compositions and methods for gene editing
EP3362104A4 (de) Verfahren und zusammensetzungen mit mit verwendung von cpf1 zum rna-geführten gen-editing
EP3532613A4 (de) Verfahren und zusammensetzungen zum rna-mapping
EP3596213A4 (de) Zusammensetzungen und verfahren für erhöhte genexpression
EP3350315A4 (de) Verfahren zur autokatalytischen genombearbeitung und neutralisierung von autokatalytischer genombearbeitung sowie zusammensetzungen daraus
EP3379935A4 (de) Verfahren und zusammensetzungen zur reduktion vancomycin-resistenten enterokokken
EP3625340A4 (de) Genomeditiersystem
EP3256487A4 (de) Zusammensetzungen und verfahren zur epigenombearbeitung
EP3405577B8 (de) Zusammensetzungen und verfahren zur hemmung des faktors d
EP3328363A4 (de) Zusammensetzungen und verfahren zur immunmodulation
EP3715461A4 (de) Genom-editing-zusammensetzung unter verwendung von crispr/cpf1-system und verwendung davon
EP3288387A4 (de) Mikrobielle zusammensetzungen und verfahren für bioprotektion
EP3512329A4 (de) Verfahren und zusammensetzungen zum genom-editing mittels haploider induktion
EP3448981A4 (de) Zusammensetzungen und verfahren zur durchführung von magnetschwebetrennungen
WO2017107898A9 (en) Compositions and methods for gene editing
EP3503879A4 (de) Zusammensetzung und verfahren dafür
EP3442543A4 (de) Zusammensetzungen und verfahren für neurogenese
EP3781683A4 (de) Verfahren und zusammensetzungen zur genom-editierung
EP3436083A4 (de) Neuartige zusammensetzungen und verfahren
EP3546575A4 (de) Genomeditierungsverfahren
EP3352800A4 (de) Verfahren und zusammensetzungen zur reduktion von metastasen

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200106

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
RAV Requested validation state of the european patent: fee paid

Extension state: TN

Effective date: 20200106

Extension state: MA

Effective date: 20200106

A4 Supplementary search report drawn up and despatched

Effective date: 20210312

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 15/82 20060101AFI20210308BHEP

Ipc: A01H 6/46 20180101ALI20210308BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20220829